Pomanda estimates the enterprise value of PEACOCKS MEDICAL GROUP LIMITED at £11m based on a Turnover of £13.2m and 0.83x industry multiple (adjusted for size and gross margin).
peacocks medical group limitedEstimated Valuation
£3.2m
Pomanda estimates the enterprise value of PEACOCKS MEDICAL GROUP LIMITED at £3.2m based on an EBITDA of £521.9k and a 6.19x industry multiple (adjusted for size and gross margin).
peacocks medical group limitedEstimated Valuation
£5.9m
Pomanda estimates the enterprise value of PEACOCKS MEDICAL GROUP LIMITED at £5.9m based on Net Assets of £3m and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Peacocks Medical Group LimitedOverview
Peacocks Medical Group Limited is a live company located in newcastle upon tyne, NE6 4NQ with a Companies House number of 00560972. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in February 1956, it's largest shareholder is
the peacock group limited
with a 100% stake. Peacocks Medical Group Limited is a mature,
mid sized company, Pomanda has estimated its turnover at
£13.2m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Peacocks Medical Group Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
6 Strong
4 Regular
2 Weak
Size
annual sales of £13.2m, make it in line with the average company (£15.3m)
£13.2m - Peacocks Medical Group Limited
£15.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (6.5%)
10% - Peacocks Medical Group Limited
6.5% - Industry AVG
Production
with a gross margin of 37.5%, this company has a comparable cost of product (39.1%)
37.5% - Peacocks Medical Group Limited
39.1% - Industry AVG
Profitability
an operating margin of 2.6% make it less profitable than the average company (5.7%)
2.6% - Peacocks Medical Group Limited
5.7% - Industry AVG
Employees
with 1543 employees, this is above the industry average (66)
1543 - Peacocks Medical Group Limited
66 - Industry AVG
Pay Structure
on an average salary of £4k, the company has a lower pay structure (£54k)
£4k - Peacocks Medical Group Limited
£54k - Industry AVG
Efficiency
resulting in sales per employee of £8.5k, this is less efficient (£242.6k)
£8.5k - Peacocks Medical Group Limited
£242.6k - Industry AVG
Debtor Days
it gets paid by customers after 49 days, this is near the average (49 days)
49 days - Peacocks Medical Group Limited
49 days - Industry AVG
Creditor Days
its suppliers are paid after 71 days, this is slower than average (33 days)
71 days - Peacocks Medical Group Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 32 days, this is less than average (77 days)
32 days - Peacocks Medical Group Limited
77 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 24 weeks, this is more cash available to meet short term requirements (13 weeks)
24 weeks - Peacocks Medical Group Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 43.4%, this is a similar level of debt than the average (45%)
43.4% - Peacocks Medical Group Limited
45% - Industry AVG
PEACOCKS MEDICAL GROUP LIMITED financials
EXPORT
Peacocks Medical Group Limited's latest turnover from May 2023 is £13.2 million and the company has net assets of £3 million. According to their latest financial statements, Peacocks Medical Group Limited has 1,543 employees and maintains cash reserves of £1.1 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Turnover
13,181,023
11,354,389
8,941,025
9,888,141
10,463,321
9,770,432
9,253,407
9,499,664
11,445,386
10,787,325
10,794,374
10,534,788
10,044,979
10,781,608
Other Income Or Grants
Cost Of Sales
8,240,430
7,033,044
5,516,530
6,552,553
7,004,830
6,466,380
6,140,677
5,948,264
8,797,263
8,215,818
8,102,476
8,144,746
7,793,355
8,099,870
Gross Profit
4,940,593
4,321,345
3,424,495
3,335,588
3,458,491
3,304,052
3,112,730
3,551,400
2,648,123
2,571,507
2,691,898
2,390,042
2,251,624
2,681,738
Admin Expenses
4,599,315
4,266,265
3,419,612
3,361,233
4,039,633
3,938,572
3,255,607
3,639,562
2,739,947
2,511,386
2,301,891
2,236,087
2,086,645
2,582,835
Operating Profit
341,278
55,080
4,883
-25,645
-581,142
-634,520
-142,877
-88,162
-91,824
60,121
390,007
153,955
164,979
98,903
Interest Payable
3,689
2,926
86,832
46,390
34,205
23,767
15,730
7,568
672
2,626
15,497
25,288
Interest Receivable
23,513
22,500
30,000
59
801
Pre-Tax Profit
337,589
52,154
-81,949
-72,035
-591,834
-635,787
-128,607
367,986
-91,765
60,922
389,335
151,329
149,482
73,615
Tax
152,108
489,798
228,460
316,528
322,829
408,694
181,686
-24,101
6,342
-17,635
-78,302
-28,746
-24,344
-14,527
Profit After Tax
489,697
541,952
146,511
244,493
-269,005
-227,093
53,079
343,885
-85,423
43,287
311,033
122,583
125,138
59,088
Dividends Paid
146,695
155,360
104,791
72,000
72,000
193,643
72,000
112,133
Retained Profit
343,002
386,592
41,720
244,493
-269,005
-299,093
-18,921
150,242
-157,423
-68,846
311,033
122,583
125,138
59,088
Employee Costs
6,123,253
5,163,200
4,859,595
5,212,004
5,078,376
4,936,590
4,842,104
4,727,630
4,969,266
4,409,805
4,099,622
4,163,092
4,250,123
4,252,073
Number Of Employees
1,543
144
147
173
172
166
172
170
179
160
150
157
166
171
EBITDA*
521,867
442,214
378,552
255,777
-289,497
-337,051
145,350
192,896
196,012
270,007
615,832
379,805
363,336
276,228
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Tangible Assets
637,721
602,136
610,274
698,482
453,536
447,663
521,120
571,960
1,596,014
1,537,280
1,271,052
829,102
684,404
622,718
Intangible Assets
29,169
945,636
1,160,341
721,910
835,818
928,147
881,504
30,661
8,334
Investments & Other
2
Debtors (Due After 1 year)
546,013
522,500
500,000
Total Fixed Assets
666,890
602,136
1,555,910
1,858,823
1,721,459
1,805,981
1,949,267
1,453,466
1,626,675
1,545,614
1,271,052
829,102
684,404
622,718
Stock & work in progress
737,132
552,540
769,524
820,053
804,739
714,538
731,318
726,995
874,354
724,055
732,940
781,226
844,712
967,286
Trade Debtors
1,804,000
1,809,694
943,053
817,334
1,573,482
1,619,255
1,939,057
1,630,773
2,225,380
1,505,439
1,564,800
1,862,610
1,794,303
2,219,647
Group Debtors
329,383
115,254
Misc Debtors
1,030,360
752,271
759,773
1,051,023
945,021
695,581
353,454
203,358
176,315
270,180
299,360
149,046
131,890
318,764
Cash
1,056,766
929,566
1,039,950
95,867
35,275
97,941
226,560
4,193
10,526
1,175,155
620,295
22,655
149,356
215,860
misc current assets
total current assets
4,628,258
4,373,454
3,512,300
2,899,531
3,358,517
3,127,315
3,250,389
2,565,319
3,286,575
3,674,829
3,217,395
2,815,537
2,920,261
3,721,557
total assets
5,295,148
4,975,590
5,068,210
4,758,354
5,079,976
4,933,296
5,199,656
4,018,785
4,913,250
5,220,443
4,488,447
3,644,639
3,604,665
4,344,275
Bank overdraft
363,836
1,004,071
916,665
826,800
305,765
392,892
5,726
536,694
Bank loan
Trade Creditors
1,613,507
1,302,370
728,744
818,440
961,938
829,324
962,679
978,503
1,163,631
1,609,201
1,106,685
805,768
776,035
822,963
Group/Directors Accounts
91,618
258,358
1,468,677
1,517,056
496,104
1,052,874
other short term finances
223,129
149,743
hp & lease commitments
4,256
9,927
51,468
other current liabilities
284,764
1,113,470
1,854,371
1,385,835
1,000,586
824,416
1,748,598
673,723
1,212,021
1,288,991
1,020,879
752,076
801,847
952,876
total current liabilities
2,262,107
2,415,840
2,897,862
2,612,376
4,435,272
4,087,461
4,034,181
3,010,865
2,768,544
2,898,192
2,127,564
1,567,826
1,587,809
2,364,001
loans
hp & lease commitments
4,618
14,845
Accruals and Deferred Income
32,200
38,040
43,880
49,720
other liabilities
1,300,000
1,300,000
provisions
37,251
61,287
107,533
124,883
135,902
62,188
76,895
94,579
81,180
87,522
69,887
38,297
35,506
26,562
total long term liabilities
37,251
61,287
1,407,533
1,424,883
168,102
100,228
120,775
144,299
81,180
87,522
69,887
38,297
40,124
41,407
total liabilities
2,299,358
2,477,127
4,305,395
4,037,259
4,603,374
4,187,689
4,154,956
3,155,164
2,849,724
2,985,714
2,197,451
1,606,123
1,627,933
2,405,408
net assets
2,995,790
2,498,463
762,815
721,095
476,602
745,607
1,044,700
863,621
2,063,526
2,234,729
2,290,996
2,038,516
1,976,732
1,938,867
total shareholders funds
2,995,790
2,498,463
762,815
721,095
476,602
745,607
1,044,700
863,621
2,063,526
2,234,729
2,290,996
2,038,516
1,976,732
1,938,867
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Operating Activities
Operating Profit
341,278
55,080
4,883
-25,645
-581,142
-634,520
-142,877
-88,162
-91,824
60,121
390,007
153,955
164,979
98,903
Depreciation
178,300
171,177
151,814
113,997
128,977
139,542
141,793
140,221
282,980
209,886
225,825
225,850
198,357
177,325
Amortisation
2,289
215,957
221,855
167,425
162,668
157,927
146,434
140,837
4,856
Tax
152,108
489,798
228,460
316,528
322,829
408,694
181,686
-24,101
6,342
-17,635
-78,302
-28,746
-24,344
-14,527
Stock
184,592
-216,984
-50,529
15,314
90,201
-16,780
4,323
-147,359
150,299
-8,885
-48,286
-63,486
-122,574
967,286
Debtors
-56,988
1,188,522
-280,785
-1,080,905
227,180
44,825
958,380
-567,564
626,076
-88,541
-147,496
85,463
-612,218
2,538,411
Creditors
311,137
573,626
-89,696
-143,498
132,614
-133,355
-15,824
-185,128
-445,570
502,516
300,917
29,733
-46,928
822,963
Accruals and Deferred Income
-828,706
-740,901
468,536
353,049
170,330
-930,022
1,069,035
-488,578
-76,970
268,112
268,803
-49,771
-151,029
952,876
Deferred Taxes & Provisions
-24,036
-46,246
-17,350
-11,019
73,714
-14,707
-17,684
13,399
-6,342
17,635
31,590
2,791
8,944
26,562
Cash flow from operations
4,766
-253,047
1,299,816
1,836,428
92,609
-1,034,486
399,860
223,411
-1,102,903
1,138,061
1,334,622
311,835
884,771
-1,441,595
Investing Activities
capital expenditure
-245,343
566,640
-70,756
-964,799
-183,610
-131,683
-284,030
-107,847
-367,985
-485,443
-678,596
-404,628
-260,349
301,984
Change in Investments
-2
2
cash flow from investments
-245,343
566,640
-70,756
-964,799
-183,610
-131,683
-284,028
-107,849
-367,985
-485,443
-678,596
-404,628
-260,349
301,984
Financing Activities
Bank loans
Group/Directors Accounts
-91,618
-166,740
-1,210,319
-48,379
1,020,952
-556,770
1,052,874
Other Short Term Loans
-223,129
73,386
149,743
Long term loans
Hire Purchase and Lease Commitments
-4,256
-10,289
-51,768
66,313
other long term liabilities
-1,300,000
1,300,000
share issue
154,325
1,349,056
200,000
-1,350,147
-13,780
12,579
-58,553
-60,799
-87,273
1,879,779
interest
-3,689
-2,926
-86,832
-46,390
-10,692
-1,267
14,270
-7,568
59
801
-672
-2,626
-15,497
-25,288
cash flow from financing
150,636
-268,617
-180,186
193,034
-59,071
1,019,685
-342,500
-304,841
-13,721
13,380
-63,481
-73,714
-154,538
1,920,804
cash and cash equivalents
cash
127,200
-110,384
944,083
60,592
-62,666
-128,619
222,367
-6,333
-1,164,629
554,860
597,640
-126,701
-66,504
215,860
overdraft
363,836
-1,004,071
87,406
89,865
521,035
-87,127
392,892
-5,726
5,726
-536,694
536,694
change in cash
-236,636
-110,384
944,083
1,064,663
-150,072
-218,484
-298,668
80,794
-1,557,521
554,860
603,366
-132,427
470,190
-320,834
peacocks medical group limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for peacocks medical group limited. Get real-time insights into peacocks medical group limited's credit score, group structure and payment trends.
Peacocks Medical Group Limited Competitor Analysis
Perform a competitor analysis for peacocks medical group limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in NE6 area or any other competitors across 12 key performance metrics.
peacocks medical group limited Ownership
PEACOCKS MEDICAL GROUP LIMITED group structure
Peacocks Medical Group Limited has no subsidiary companies.
The sole shareholder of Peacocks Medical Group Limited is The Peacock Group Limited.
the peacock group limited
100%
peacocks medical group limited directors
Peacocks Medical Group Limited currently has 4 directors.
The longest serving directors include
Mr John Peacock (Dec 1991) and
Mr Terence Gumbley (May 2004).
unit c1 benfield business park, benfield road, newcastle upon tyne, tyne & wear, NE6 4NQ
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
peacocks medical group limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 12 charges/mortgages relating to peacocks medical group limited. Currently there are 1 open charges and 11 have been satisfied in the past.
peacocks medical group limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PEACOCKS MEDICAL GROUP LIMITED. This can take several minutes, an email will notify you when this has completed.
peacocks medical group limitedCompanies House Filings - See Documents
